WeVote
Log In

Bill

DB

Bill

S 2886

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

2024-2025 Regular Session Introduced by Dave Bailey and 9 co-sponsors

New Jersey pharmacies must display a notice and provide a pamphlet about insulin manufacturer assistance programs to customers, with content set by the health department.

Approved P.L.2025, c.90.
#pharmaceutic
0
WeVote Research Nonpartisan
Bill Summary · S 2886

Summary — S2886 (P.L.2025, c.90)

An Act requiring New Jersey pharmacy practice sites to provide information about insulin manufacturer assistance programs and directing the Department of Health to create the notice and pamphlet materials and adopt implementing regulations.

Purpose

To improve patient awareness of manufacturer assistance programs that can help reduce out-of-pocket costs or provide financial support for insulin by ensuring pharmacies communicate available program information to customers.

Key provisions

  • Pharmacy obligations
    • Each pharmacy practice site must display, in a conspicuous manner on the pharmacy’s website, a notice concerning insulin manufacturer assistance programs. The content of that notice will be created by the New Jersey Department of Health.
    • At an individual’s request, the pharmacy must provide a pamphlet (also created by the Department of Health) about insulin manufacturer assistance programs to any person purchasing an insulin prescription and to any person who requests the pamphlet.
  • Manufacturer participation
    • Insulin manufacturers that offer an assistance program may notify the Department of Health of their intention to be included in the notices and pamphlets (participation is voluntary).
  • Rulemaking and administration
    • The Department of Health must adopt rules and regulations under the Administrative Procedure Act to implement the law.
  • Effective date
    • The law takes effect on the first day of the twelfth month following enactment (i.e., roughly 12 months after the date the act was signed), but the Commissioner of Health may take anticipatory administrative actions in advance to implement the act.

Who is affected

  • Pharmacies and pharmacy practice sites operating in New Jersey — required to post website notices and distribute pamphlets upon request.
  • The New Jersey Department of Health — responsible for preparing notice and pamphlet content and issuing rules.
  • Insulin manufacturers — may elect to be included in Department-provided materials.
  • Individuals purchasing insulin or seeking information about assistance programs — the primary beneficiaries who will have easier access to information about manufacturer assistance.

Implementation and enforcement

  • The statute requires Department rulemaking to effectuate the provisions; the text does not specify civil penalties or enforcement mechanisms for noncompliance within the printed law.
  • Enacted as P.L.2025, c.90 and approved July 8, 2025; effective approximately 12 months after enactment.

Legislative history (highlights)

  • Introduced in the NJ Senate: March 4, 2024
  • Passed Senate: Feb. 25, 2025 (38–0)
  • Passed Assembly: May 22, 2025 (77–0–0)
  • Approved (signed into law): July 8, 2025 (P.L.2025, c.90)

Note: The statute supplements existing pharmacy practice law (P.L.2003, c.280, C.45:14-40 et seq.).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.